Algene Holding SE, a subsidiary of DN Group AG (ISIN: DE000A3DW408), announced the first harvest of high-purity microalgae, achieving a total yield of 4,500 litres. This milestone moves the company into series production after successful up-scaling, targeting particularly quality-critical products in the cosmetics and food industries, with potential for pharmaceutical applications. The Algene platform was developed in cooperation with the Technical University of Munich and is now set for series production.
Algene has entered extensive talks with well-known cosmetics companies for the purchase of microalgae. The initial delivery to a leading German cosmetics manufacturer is planned for the coming days, with the biomass primarily used for laboratory tests and validation of active ingredients. This step underscores the market acceptance of Algene's high-quality material.
The market for algae as a strategic resource is growing dynamically. According to the EU Commission, the European market is projected to reach approximately 9 billion euros from 2030 onwards. Algae are considered a key building block of the bioeconomy. In this rapidly expanding market, Algene Holding is positioning itself as an industrial platform for controlled microalgae production, addressing segments such as nutrition & food, cosmetics, life sciences, and aquaculture.
Ole Nixdorff, CEO of DN Group, stated: "For Algene, the start of series production is an important milestone. The market for microalgae is growing rapidly and offers enormous potential. The high level of interest underlines the high quality of the Algene material and the good market acceptance. As a shareholder in Algene, DN Group participates in this future market."
DN Group AG invests in impact companies with high growth opportunities in future industries such as AI, mobility, circular economy, food, health, and energy, supporting them in successful IPOs. DN Group is one of the leading providers of IPO and capital market transaction advice, connecting fast-growing ESG companies with international institutional investors. For more information, visit www.dn-ag.com.
View the original release on www.newmediawire.com.
